GOSSAMER BIO INC (GOSS) Stock News

NASDAQ:GOSS - US38341P1021 - Common Stock

3.27 USD

+0.16 (+5.14%)

Last: 9/11/2025, 10:13:08 AM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

GOSS Latest News, Press Relases and Analysis

All

Press Releases

17 hours ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

a day ago - By: Benzinga - Mentions: SAIA HPQ NEM NKE

This Saia Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday

13 days ago - By: Gossamer Bio, Inc.

Gossamer Bio to Present at Upcoming Investor Conferences

a month ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

4 months ago - By: Benzinga

Exploring Gossamer Bio's Earnings Expectations

a month ago - By: Zacks Investment Research - Mentions: VSTM

Gossamer Bio (GOSS) Reports Q2 Loss, Beats Revenue Estimates

a month ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Second Quarter 2025 Financial Results and Provides Business Update

a month ago - By: Zacks Investment Research - Mentions: HRMY

Harmony Biosciences Holdings, Inc. (HRMY) Misses Q2 Earnings and Revenue Estimates

3 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Completion of Enrollment in Registrational Phase 3 PROSERA Study for the Treatment of PAH

3 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

4 months ago - By: Zacks Investment Research - Mentions: ROIV

Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates

4 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces First Quarter 2025 Financial Results and Provides Business Update, Including Closure of New Patient Screening in Phase 3 PROSERA Study

4 months ago - By: Yahoo Finance - Mentions: PYPL

FTA to defend open banking in court

4 months ago - By: Gossamer Bio, Inc.

Gossamer Bio to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15, 2025

4 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

4 months ago - By: Gossamer Bio, Inc.

Gossamer Bio to Present Preclinical Data at the American Thoracic Society (ATS) 2025 International Conference

5 months ago - By: Yahoo Finance - Mentions: DB BTU EQH NVDA ...

Peabody pauses seeking debt for partial refinance of $2.1bn private loan

5 months ago - By: Yahoo Finance - Mentions: GERN CAN GILD NUVB ...

Is Geron Corp. (NASDAQ:GERN) the Best Biotech Penny Stock to Buy According to Hedge Funds?

5 months ago - By: Yahoo Finance - Mentions: ECX CAN AIG PLTR ...

Is Ecarx Holdings Inc. (NASDAQ:ECX) the Best Penny Stock to Invest in Under $1?

5 months ago - By: Yahoo Finance - Mentions: ALSN CAN NUVB BTU ...

Is Gossamer Bio Inc. (NASDAQ:GOSS) the Best Penny Stock to Invest in Under $1?

5 months ago - By: Yahoo Finance - Mentions: COIN AMD DG NVDA ...

Coinbase price target lowered to $275 from $390 at Monness Crespi

5 months ago - By: Yahoo Finance - Mentions: RLAY KIND DAWN BG ...

Relay Therapeutics, Inc. (RLAY): Among Stocks Under $10 that Will Triple

5 months ago - By: Yahoo Finance - Mentions: PRLD DAWN VIR NUVB ...

Gossamer Bio, Inc. (GOSS): Among Stocks Under $10 that Will Triple

5 months ago - By: Yahoo Finance - Mentions: NUVB RLAY TSLA DAWN ...

Nuvation Bio Inc. (NUVB): Among Stocks Under $10 that Will Triple

5 months ago - By: Yahoo Finance - Mentions: NTLA NUVB IBRX VSAT ...

Intellia Therapeutics, Inc. (NTLA): Among Stocks Under $10 that Will Triple

5 months ago - By: Yahoo Finance - Mentions: PLTR COMP MRVL AJG ...

1 Artificial Intelligence (AI) Growth Stock That Could Soar Thanks to Trump's Tariffs

5 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

6 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

6 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

7 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

7 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress

8 months ago - By: Gossamer Bio, Inc.

Gossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress

8 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

10 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

10 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update

a year ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)